|
已选(0)清除
条数/页： 排序方式： |
| Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
  收藏 | 浏览/下载：29/0 | 提交时间：2020/10/26
SARCOMATOID HEPATOCELLULAR-CARCINOMA CLEAR-CELL CARCINOMA OF-THE-LITERATURE CHOLANGIOCELLULAR CARCINOMA GIANT-CELLS CHOLANGIOCARCINOMA DIAGNOSIS SURGERY Clear cell carcinoma combined hepatocellular-cholangiocarcinoma giant cell carcinoma sarcomatoid carcinoma hepatocellular carcinoma |
| Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：24/0 | 提交时间：2020/10/26
SOLITARY PLASMACYTOMA RADIATION-THERAPY CLINICAL-FEATURES ONCOLOGY-GROUP SOFT-TISSUE NECK HEAD BONE MULTICENTER GUIDELINES Extramedullary plasmacytoma prognostic factors radiotherapy multiple myeloma |
| Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：33/0 | 提交时间：2020/10/26
EGFR MUTATIONS GEFITINIB TREATMENT 1ST-LINE TREATMENT OPEN-LABEL RARE MULTICENTER ERLOTINIB GENE CHEMOTHERAPY EFFICACY Non-small cell lung cancer EGFR uncommon mutation target therapy |
| Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method: a single-center large-scale investigation of 1,504 Chinese Han patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2016, 卷号: 28
-
收藏 | 浏览/下载：43/0 | 提交时间：2020/10/26
EML4-ALK FUSION CANCER ADENOCARCINOMA PCR EXPERIENCE FISH GENE Anaplastic lymphoma kinase (ALK) rearrangements fully automated immunohistochemistry (IHC) clinicopathological analysis targeted therapy |
| Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2011, 卷号: 23
-
收藏 | 浏览/下载：34/0 | 提交时间：2020/10/26
TUMOR-SUPPRESSOR GENE ABERRANT METHYLATION PROSTATE-CANCER HEPATOCELLULAR-CARCINOMA EPIGENETIC ALTERATIONS PROLIFERATION CARCINOGENESIS RESTORATION EXPRESSION MIGRATION DLC1 Colorectal cancer Methylation Biomarker |
